Dr. Daniel J Canney was appointed the interim director of the Moulder Center for Drug Discovery Research in July, 2020 and is an associate professor of medicinal chemistry in the department of pharmaceutical sciences at Temple University School of Pharmacy. Dr. Canney obtained a B.S. degree in pharmacy (1979) and earned his PhD. in medicinal chemistry at Temple University.Temple School of Pharmacy (1986). He then accepted a position as a postdoctoral fellow in the Department of Pharmacology and Molecular Biology at Washington University School of Medicine, St. Louis where he worked on the development of novel anticonvulsant agents (1987-1990). He later joined the University of Pennsylvania's Department of Radiology (Section of Radiopharmaceutical Chemistry) as a research assistant professor (1990-1993) where he worked on the development of organ and receptor-specific imaging agents for use in SPECT imaging studies (technetium and radioiodinated ligands). Dr. Canney joined the faculty of Temple University School of Pharmacy in 1993 as assistant professor of medicinal chemistry. Prior to his appointment as the Moulder Center’s interim director, Dr. Canney held positions as the chairperson of the department of pharmaceutical sciences (2011-2018) and the director of graduate studies (2011-2020). He also serves as the Faculty Advisor for the Rho Chi Pharmaceutical Honor Society and on the Committee on Addiction and Substance Abuse (C.A.S.A.,Rx). Dr. Canney’s current research interests include structure-activity relationship (SAR) studies involving molecules that modulate pharmacologically important protein targets. Examples include novel ligands for cholinergic (muscarinic and nicotinic), serotonin, and Sigma receptor subtypes.
Moulder Center for Drug Discovery Research
Temple University School of Pharmacy
3307 N Broad Street
Philadelphia, PA 19140